tiprankstipranks
Trending News
More News >
Biosergen AB (DE:8N1)
FRANKFURT:8N1
Germany Market

Biosergen AB (8N1) Income Statement

Compare
1 Followers

Biosergen AB Income Statement

Last quarter (Q4 2024), Biosergen AB's total revenue was kr0.00, a decrease of ― from the same quarter last year. In Q4, Biosergen AB's net income was kr-3.75M. See Biosergen AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 0.00kr 0.00kr 0.00kr 8.57Mkr 4.43M
Gross Profit
kr 0.00kr -456.00Kkr -280.00Kkr 8.39Mkr -6.10M
Operating Expenses
kr 18.59Mkr 26.81Mkr 33.85Mkr 33.90Mkr 6.23M
Depreciation and Amortization
kr 0.00kr 27.27Mkr -5.86Mkr 40.89Mkr 206.30K
EBITDA
kr -18.59Mkr 228.00Kkr -39.99Mkr 0.00kr -6.72M
Operating Income
kr -18.59Mkr -27.27Mkr -34.13Mkr -34.08Mkr -6.23M
Other Income/Expenses
kr -202.00Kkr 228.00Kkr 81.00Kkr -240.00Kkr -498.00K
Pretax Income
kr -18.79Mkr -27.04Mkr -34.05Mkr -34.32Mkr -6.72M
Net Income
kr -18.79Mkr -27.04Mkr -33.91Mkr -34.56Mkr -7.22M
Per Share Metrics
Basic EPS
kr -0.08kr -0.60kr -0.64kr -0.65kr -0.03
Diluted EPS
kr -0.08kr -0.60kr -0.64kr -0.65kr -0.03
Weighted Average Shares Outstanding
234.82M 44.93M 52.76M 53.49M 207.24M
Weighted Average Shares Outstanding (Diluted)
234.82M 44.93M 52.76M 53.49M 207.24M
Currency in SEK

Biosergen AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis